_____МЖ__ новый_17 apr_connent

Содержание

Слайд 2

Anatomy of the bile ducts

Bile Duct Diseases - Harvard Health

Anatomy and

Anatomy of the bile ducts Bile Duct Diseases - Harvard Health Anatomy
flow of bile. Sphincter of Oddi regulates bile flow. Liver secretes bile constantly, closed sphincter of Oddi ensures filling of gallbladder, open sphincter is followed by bile drainage from the gallbladder towards duodenum. Bile duct obstruction causes biliary hypertension. Reliability of biliary system – bile duct lumen of 1 mm is enough for daily bile passage.

2

Слайд 3

Anatomy of hepatic lobule

Substrates from sinusoid normally pass into the hepatocytes. After

Anatomy of hepatic lobule Substrates from sinusoid normally pass into the hepatocytes.
metabolic transformation, some metabolites (bile, bile acids, etc.) pass into the bile capillary. A part of metabolized substrates return to sinusoid and pass into systemic circulation.

1 – bile capillary
2 – layer of hepatocytes
3 – space of Disse
4 – sinusoid
5 – portal vein branch
6 – hepatic artery branch

2a

Слайд 4

Definition: any impairment of secretion and release of bile from the hepatocyte

Definition: any impairment of secretion and release of bile from the hepatocyte
to the major duodenal papilla is called cholestasis. Thus, this concept includes both biochemical and mechanical disorders.
Cholestasis is a universal liver reaction against any type of lesion (ischemic, toxic, obstructive, metabolic, autoimmune).
Types of cholestasis: extrahepatic (biliary hypertension, obstructive jaundice), intrahepatic, combined.

Cholestasis

3

Слайд 5

Cholemia
Homeostasis disorders: vascular dilatation, reduced peripheral vascular resistance and total blood volume,

Cholemia Homeostasis disorders: vascular dilatation, reduced peripheral vascular resistance and total blood
bradycardia, vagal effects, reduced renal glomerular filtration.
Dysfunction of RES (80% of cells in liver), Kupffer cells, inflammatory cytokine release (TNFα, IL6, IL8, etc.), endothelial dysfunction.

4

Acholia

Acholia is followed by advanced bacterial colonization of bowel, release of toxins and their translocation into portal blood. One microbe decays to form 3 million molecules of lipopolysaccharide toxin (LPS).
Functional overload of Kupffer cells associated with cholemia and advanced flow of microbes and toxins causes their partial dysfunction that leads to translocation of bacteria and toxins into systemic circulation, development of systemic inflammatory response and multiple organ failure.
Jaundice is a universal liver response to adverse effects resulting dramatic changes in various systems.

Слайд 6

Painful and painless obstructive jaundice

Various rates of biliary hypertension development (fast, sudden

Painful and painless obstructive jaundice Various rates of biliary hypertension development (fast,
or slow, gradual) determine occurrence of painful or painless obstructive jaundice. Sudden biliary hypertension is followed by acute pain in the right upper abdominal quadrant. Slow progression of biliary hypertension determines painless jaundice. Fast development of biliary hypertension is mainly observed in cholangiolithiasis, a slow one – in patients with bile duct tumors.

4

Слайд 7

PAINFUL OBSTRUCTIVE JAUNDICE

5

PAINFUL OBSTRUCTIVE JAUNDICE 5

Слайд 8

Cholangiolithiasis

Gallstone migration from the gallbladder.
Obstruction of common hepatic duct and common bile

Cholangiolithiasis Gallstone migration from the gallbladder. Obstruction of common hepatic duct and
duct.
Obstruction of major duodenal papilla.

6

Слайд 9

Stenosis of major duodenal papilla

Causes: cholangitis, pancreatitis, instrumental injury, gallstone passage, parapapillary

Stenosis of major duodenal papilla Causes: cholangitis, pancreatitis, instrumental injury, gallstone passage,
diverticulum, functional disorders of the sphincter of Oddi.
Morphological changes: fibrosclerotic disorders.
Symptoms: pain, intermittent jaundice, urine and stool discoloration.
Diagnosis: endoscopic examination of major duodenal papilla, ERCP, PTC, manometry.
Treatment: endoscopic or surgical intervention for severe stenosis.

7

Слайд 10

Choledocholithiasis. Ultrasound

Dilatation of the bile ducts, doubling of the tubular structure
Calculi in

Choledocholithiasis. Ultrasound Dilatation of the bile ducts, doubling of the tubular structure
the bile ducts
Endoscopic ultrasound – small calculi
Sensitivity of ultrasound – 28-50%, endoscopic ultrasound– 98%.

а – ultrasound: common bile duct enlargement and calculus (arrow).

б – ultrasound: calculus inside the common bile duct (arrow).

в – endoscopic ultrasound: a small calculus is visualized (arrow).

8

Слайд 11

ERCP

ERCP – diagnosis of calculi (а, arrow), hepatic duct injury after laparoscopic

ERCP ERCP – diagnosis of calculi (а, arrow), hepatic duct injury after
surgery (б, arrow).
Sensitivity – 89-98%.

9

Слайд 12

PTC

Mirizzi syndrome. Hepatic duct calculi. Sensitivity - 90-100%.

10

PTC Mirizzi syndrome. Hepatic duct calculi. Sensitivity - 90-100%. 10

Слайд 13

MRCP. МR-cholangiography

Imaging of gallbladder, bile ducts and calculi (arrows) without contrast enhancement. Sensitivity

MRCP. МR-cholangiography Imaging of gallbladder, bile ducts and calculi (arrows) without contrast enhancement. Sensitivity 85–88%. 11
85–88%.

11

Слайд 14

ERCP vs. MRCP

ERCP
A relatively invasive method requires contrast agent injection into

ERCP vs. MRCP ERCP A relatively invasive method requires contrast agent injection
the bile ducts, biliary hypertension and irradiation.

Calculi

Calculi

MRCP
Non-invasive method without the need for direct contrast enhancement of the bile ducts. Less clear image, but no irradiation.

Images were obtained from the same patient. Calculi were removed via endoscopic approach.

12

Слайд 15

Mirizzi syndrome

Type I - narrowing of common hepatic duct caused by calculus-induced

Mirizzi syndrome Type I - narrowing of common hepatic duct caused by
compression of Hartmann's pouch

Type II - fistula between the gallbladder and hepatic duct. Hypertension of lobar hepatic ducts

13

Слайд 16

Bile duct cysts. Classification

Todani classification

Cysts are diagnosed in patients aged 3

Bile duct cysts. Classification Todani classification Cysts are diagnosed in patients aged
months - 16 years and often cause obstruction of the bile ducts
Hereditary disease
No muscle layer and collagen fibers. Liver fibrosis
Periductal eosinophilic infiltration

14

Слайд 17

Caroli disease (cystic lesion type V) Surgery – liver resection

15

Caroli disease (cystic lesion type V) Surgery – liver resection 15

Слайд 18

Primary sclerosing cholangitis

Chronic course
Cause is unclear
Multiple strictures and dilatations

Primary sclerosing cholangitis Chronic course Cause is unclear Multiple strictures and dilatations
of intrahepatic bile ducts
Outcome: liver cirrhosis, cholangiocarcinoma is rarer
Diagnosis: direct contrast enhanced methods, MRCP
Radical approach – liver transplantation

Idiopathic gallbladder obliteration, autoimmune disease, frequent combination with ulcerative colitis, Crohn's disease. Higher-than-normal levels of AST and ALP.

16

Слайд 19

Haemobilia


Damage to the liver or intrahepatic bile ducts, local liver necrosis.

Haemobilia Damage to the liver or intrahepatic bile ducts, local liver necrosis.
Haemobilia is a secondary sign of the underlying disease.
Right upper quadrant abdominal pain, melena, transient jaundice.
Endoscopic examination of major duodenal papilla, ERCP, angiography, ultrasound, CT, MRI
Mortality rate 32–50%.

17

Слайд 20

Parasitic invasion

Opisthorchiasis (Ob, Volga basin, East Asia)
Echinococcosis, alveococcosis, ascariasis,

Parasitic invasion Opisthorchiasis (Ob, Volga basin, East Asia) Echinococcosis, alveococcosis, ascariasis, Fascioliasis–
Fascioliasis– Fasciola gigantica
Schistosomiasis – tropical helminth
Parasites penetrate into the bile ducts from the duodenum

18

Слайд 21

Symptoms and diagnosis of painful obstructive jaundice

Acute onset
Scleral icterus
Pain attack
Dark urine, stool

Symptoms and diagnosis of painful obstructive jaundice Acute onset Scleral icterus Pain
discoloration

Common previous cholelithiasis
Ultrasound, ERCP, PTC, MRCP, CT, endoscopic ultrasound.
Laboratory survey.

19

Слайд 22

ACUTE CHOLANGITIS

20

ACUTE CHOLANGITIS 20

Слайд 23

Acute cholangitis (AC)

AC is an infectious inflammation of the bile ducts.

Acute cholangitis (AC) AC is an infectious inflammation of the bile ducts.
Most often, AC develops on the background of obstructive jaundice and biliary hypertension. AC is associated with penetration of microbes (Escherichia coli, Klebsiella, Proteus) from the duodenum into the bile ducts. Metabolic products of microbial cells cause acute biliary hypertension.

21

Слайд 24

Cholangiovenous reflux

Corrosion casting. Scanning electron microscopy

Secretory pressure. Microbial metabolite pressure.

Cholangiovenous reflux Corrosion casting. Scanning electron microscopy Secretory pressure. Microbial metabolite pressure.
L., Pellegrini C.A., Way L.W. Am. J. Surg., 1988; 155: 23–28.

* Particle of 1,7 µm – is a size of microbe

22

1 – bile capillary
2 – layer of hepatocytes
3 – space of Disse
4 – sinusoid
5 – portal vein branch
6 – hepatic artery branch

Слайд 25

Symptoms of acute cholangitis
Chills, fever
Leukocytosis
Infection
Symptoms associated with biliary

Symptoms of acute cholangitis Chills, fever Leukocytosis Infection Symptoms associated with biliary
hypertension and obstructive jaundice
Recurrent systemic inflammatory response with organ dysfunction

Charcot's triad:
fever, rigors, jaundice

Reynolds’ pentad :
Charcot's triad + altered mental status, hypotension

23

Слайд 26

Causes of short-term SIRS and symptoms of sepsis

Two factors:
Large purulent surface

Causes of short-term SIRS and symptoms of sepsis Two factors: Large purulent
of gallbladder, direct biliovenous reflux - sinusoidal endotoxemia
Kupffer cell failure caused by cholemia - systemic endotoxemia, increased release of pro-inflammatory cytokines – systemic inflammatory response, sepsis.
The difference between cholangitis and other purulent diseases is high sinusoidal endotoxemia combined with Kupffer cell failure.

24

Слайд 27

Criteria of SIRS and sepsis

Body temperature > 38ºC or < 36ºC
Heart rate

Criteria of SIRS and sepsis Body temperature > 38ºC or Heart rate
> 90 beats per minute
Tachypnea > 20 breaths per minute or PaCO2 < 32 mm Hg
Leukocyte count >12 000 or < 4000
SIRS = 2 criteria
SIRS + infection = sepsis

Consensus conference of ACCP and SCCM, 1991

Severe sepsis: oliguria <500 ml/day, encephalopathy
Septic shock: BP < 90 mm Hg or reduction by 40 mm Hg

25

Слайд 28

Organ dysfunction criteria

CVS – hypotension requiring dopamine support
CNS

Organ dysfunction criteria CVS – hypotension requiring dopamine support CNS – impaired
– impaired consciousness
Respiratory system – tachypnea >20 or PaСO2 < 32 mm Hg
Kidney – serum creatinine > 2,0
Liver – hypoalbuminemia, prothrombin index↓
Coagulation – platelets < 100 000
Severe systemic dysfunction – multiple organ failure

26

Слайд 29

Renal failure in acute cholangitis

Kidney is a main organ secreting bile components

Renal failure in acute cholangitis Kidney is a main organ secreting bile
– cholemic nephropathy.
Cholemia and endotoxemia cause renin and aldosterone release, increased level of atrial natriuretic peptide, vasodilation, reducing total blood volume, renal and glomerular blood flow, arterial and venous thrombosis.
Renal failure is more common in patients with jaundice and cholangitis compared to those without jaundice.
The difference of cholangitis from other purulent diseases is high incidence of renal failure

27

Слайд 30

Management of acute cholangitis (choledocholithiasis, n = 613)

Objective: to interrupt the course

Management of acute cholangitis (choledocholithiasis, n = 613) Objective: to interrupt the
of cholangitis, to prevent sepsis.
Main measures: decompression and antimicrobial therapy.
Minimally invasive techniques (ERCP, PTC) reduced morbidity and mortality.
Data of the Hepatobiliary Surgery Department

28

Слайд 31

Treatment of pyogenic liver abscesses in acute cholangitis (n = 19) The

Treatment of pyogenic liver abscesses in acute cholangitis (n = 19) The
main requirement is biliary decompression + puncture or drainage of the abscess.

Mean duration of acute cholangitis – 8 days. Solitary – 7, multiple – 2, miliary – 10. Symptoms are significantly determined by severity of cholangitis.
Percutaneous puncture (abscess volume – 15–120 ml):
≤80 ml – efficacy 80%, >80 ml – efficacy 33%
Percutaneous drainage (abscess volume 30–160 ml).
Volume < 120 ml – efficiency is 15 times higher than for volume > 120 ml.
Duration of drainage – 10–55 days.
Surgery: drainage, liver lobe resection – 3.
Miliary abscesses – antimicrobial therapy without surgery – 10, 4 patients died.
Severe sepsis – 5, 2 patients died.
Septic shock – 7, 4 patients died.
Risk factors: miliary abscesses, septic shock, inadequate drainage, high creatinine.

29

Слайд 32

Stages of acute cholangitis and Tokyo Guidelines (2007)

*Overall and antimicrobial therapy

Emergency biliary

Stages of acute cholangitis and Tokyo Guidelines (2007) *Overall and antimicrobial therapy
decompression is required for severe acute cholangitis (stage III)
In mild stages, it is important to determine response to therapy. Emergency biliary decompression is required if there is no response (moderate, stage II).
Antibiotics enter the bile only after medical or surgical decompression. An importance of decompression in emergency surgery.

30

Слайд 33

Chronic cholangitis
Chronic cholangitis may be diagnosed in patients with:
post-traumatic strictures;
primary sclerosing

Chronic cholangitis Chronic cholangitis may be diagnosed in patients with: post-traumatic strictures;
cholangitis;
Klatskin tumors with vascular lesion;
AIDS-associated cholangitis.

Long-term course
Persistent infection
Recurrent biliary obstruction
Secondary immune deficiency (impaired response of lymphocytes to concanavalin, reduced number of NK cells, CD4/CD8 <0.5)
Secondary biliary cirrhosis is common

Chronic cholangitis in post-traumatic stricture

31

Слайд 34

Chronic cholangitis in patients with AIDS

Causative agents : Cryptosporidium and Cytomegalovirus.

Chronic cholangitis in patients with AIDS Causative agents : Cryptosporidium and Cytomegalovirus.
Features: stenosis of major duodenal papilla and bile duct enlargement, thickened walls of common bile duct (а, arrow) and gallbladder (б, arrow).
Symptoms: right upper quadrant abdominal pain and fever without jaundice and itching.
Diagnosis: ultrasound, ERCP, CT
Prognosis: life expectancy after manifestation of biliary symptoms – near 7 months

Nash J.A., Cohen S.A. Gastroenterol. Clin. N. Am. 1997; 26: 2

3+

Слайд 35

Conclusion

Acute cholangitis is characterized by purulent process proceeding on the background of

Conclusion Acute cholangitis is characterized by purulent process proceeding on the background
cholemia and acholia caused by obstructive jaundice. This determines the features of course in comparison with other purulent diseases.
Features of acute cholangitis:
Large purulent surface of gallbladder. Cholangiovenous reflux.
Advanced portal endotoxemia combined with cholemia-induced Kupffer cell failure. Systemic endotoxemia. Short-term SIRS and organ failure.
High incidence of renal failure.
Endoscopic methods ensure simultaneous diagnosis and treatment of acute cholangitis, early decompression of gallbladder in critically ill patients, and lithoextraction in 90% of patients. Endoscopic treatment reduces the risk of severe sepsis and septic shock, results low mortality and is currently preferable treatment strategy.
A distinctive feature of chronic cholangitis is recurrent gallbladder obstruction and secondary immune deficiency.

34

Слайд 36

PAINLESS OBSTRUCTIVE JAUNDICE

35

PAINLESS OBSTRUCTIVE JAUNDICE 35

Слайд 37

Tumors of bile ducts

Progressive biliary obstruction. Jaundice is the first, but not

Tumors of bile ducts Progressive biliary obstruction. Jaundice is the first, but
an early symptom. Features of Klatskin tumor and pancreatic cancer.

36

Слайд 38

Symptoms of painless obstructive jaundice

Icteric sclera and skin
Itching
Dark urine and stool discoloration
No

Symptoms of painless obstructive jaundice Icteric sclera and skin Itching Dark urine
pain as a rule
Signs of tumor growth are sometimes observed: body mass loss, no appetite, weakness

37

Слайд 39

Cancer of hepatic and common bile ducts

Common hepatic duct (Klatskin tumor) 56%

Common bile

Cancer of hepatic and common bile ducts Common hepatic duct (Klatskin tumor)
duct 44%

Obstructive jaundice following a small tumor
No metastases for a long time (nodular and papillary forms as a rule)
Proximal growth

Early local invasion
Early lymphogenous metastasizing

38

Слайд 40

Classification of hepatic duct cancer (Bismuth)

39

Classification of hepatic duct cancer (Bismuth) 39

Слайд 41

MR-cholangiography in Klatskin tumor

40

MR-cholangiography in Klatskin tumor 40

Слайд 42

Pancreatic head cancer. MRCP

41

Pancreatic head cancer. MRCP 41

Слайд 43

Differential diagnosis of obstructive and parenchymatous jaundice
Patients with a painless obstructive jaundice

Differential diagnosis of obstructive and parenchymatous jaundice Patients with a painless obstructive
do not notice anything for many days because severe symptoms are absent. Patients often admit to infectious disease departments with a diagnosis of hepatitis and undergo examination for a long time. Differential diagnosis is simple - DETECTION OF ENLARGED common bile duct during ultrasound or other surveys.

42

Слайд 44

Functional and morphological features of liver in painless obstructive jaundice

Increased levels of

Functional and morphological features of liver in painless obstructive jaundice Increased levels
direct and indirect bilirubin and alkaline phosphatase. A slight increase in AST, ALT, LDH in some patients. No other biochemical disorders.
Reduced prothrombin, platelets, rare signs of mild encephalopathy in long-standing obstructive jaundice (over 3-4 weeks).
Hepatocyte proliferation is replaced by their wrinkling and degeneration after 2-3 days (foci, fields). After 4 - 5 weeks, hepatocyte dimensions are reduced by 30-40%, their volume decreases from 97% to 40%.
Bile duct proliferation from the first day. After 4–5 weeks, their volume is increased from 2% to 40%,volume of stroma - from 1% to 20%.
Phlebitis of portal vein branches, neutrophilic infiltration, increased permeability of intercellular junctions.
Wu P.C. et al. – J. Pathol. 1981,133: 61–74.

43

Слайд 45

Metabolic disorders in painless obstructive jaundice

Reduced ATP and local blood flow velocity

Metabolic disorders in painless obstructive jaundice Reduced ATP and local blood flow
are associated with long-standing obstructive jaundice and progressive hyperbilirubinemia (p <0.05) HGF release - regeneration regulator (ATP interval 0.53-0.6 μmol/g of tissue) – the 9th day TNF-α release - apoptosis factor (decrease in ATP below 0.365 μmol/g of tissue) - after the 12th day

44

Слайд 46

Conclusion on disorders arising in painless obstructive jaundice

Painless obstructive jaundice causes severe

Conclusion on disorders arising in painless obstructive jaundice Painless obstructive jaundice causes
functional and morphological disorders in liver associated with biliary hypertension, cholestasis, cholemia and acholia.
These disturbances result extrahepatic disorders, microbial colonization of gastrointestinal tract, portal endotoxemia, RES dysfunction, especially Kupffer cells, systemic toxemia followed by organ dysfunction.
Intra- and extrahepatic disorders together with persistent obstructive jaundice and progressive hyperbilirubinemia acquire a critical nature (fragile stability state), and additional effect ("second impact") can result SIRS and multiple organ failure.

45

Слайд 47

PREOPERATIVE DECOMPRESSION

46

PREOPERATIVE DECOMPRESSION 46

Слайд 48

Preoperative decompression of the bile ducts

Methods of preoperative biliary decompression:
Percutaneous cholangiostomy.

Preoperative decompression of the bile ducts Methods of preoperative biliary decompression: Percutaneous
Endoscopic nasobiliary drainage or stenting.
Cholecystostomy: open, ultrasound-assisted laparoscopic percutaneous.
Open choledocho- or hepaticostomy.
A fairly complete restoration of liver and other systems requires prolonged decompression of the bile ducts (3-4 weeks). Therefore, various stents are often used for this purpose. For short-term decompression, drainage tubes are used. The last ones may be later replaced with stents.

Secondary obstructive jaundice is often more dangerous for the patient's life than the underlying disease that caused this syndrome. Therefore, minimally invasive correction of obstructive jaundice is essential in some patients. These patients undergo a two-stage surgery: stage 1 – bile duct decompression, correction of hyperbilirubinemia, stage 2 – total resection of tumor.

47

Слайд 49

Can bile duct decompression per se impair liver function?

In a 12-day obstructive

Can bile duct decompression per se impair liver function? In a 12-day
jaundice, decrease of ATP, progressive energy deficit of liver tissue and hyperbilirubinemia have been observed for 3 days. This the so-called post-decompression syndrome is probably associated with fast decompression of the bile ducts (similar to fast drainage of abdominal effusion).

ATP restoration after decompression in 6- and 12-day obstructive jaundice

48

Слайд 50

Comparison of various methods of bile duct decompression (n = 205)

NBD-85,

Comparison of various methods of bile duct decompression (n = 205) NBD-85,
PTC-37, cholecystostomy-63, CBD decompression -20

NBD – В = 4,6; PTC – В = 10; cholecystostomy– В = 9

NBD was followed by gradual decrease in biliary pressure throughout the entire period of decompression. An acceptable pressure was achieved by the 7th day. Other methods were characterized by faster decrease in biliary pressure. Decompression rate may be adjusted by raising or lowering the outer end of drainage tube.

49

Слайд 51

Morbidity and mortality in various rates of bile duct decompression

* –

Morbidity and mortality in various rates of bile duct decompression * –
p < 0,05

Slow decompression rate is associated with fewer complications and no mortality

– fact decompression (PTC, CS)
– slow decompression (NBD)

50

Слайд 52

Positive and negative aspects of preoperative biliary decompression


51

Opinions on stenting are

Positive and negative aspects of preoperative biliary decompression 51 Opinions on stenting
still controversial. However, there are absolute indications for preoperative biliary decompression: cholangitis, neoadjuvant chemotherapy, inoperable tumor, risk of radical surgery.
Additional factors in favor of preoperative biliary decompression: serum bilirubin > 200 mmol / L and Klatskin tumor.

Слайд 53

Features of preoperative biliary decompression in Klatskin tumor

52

Radical surgery for Klatskin

Features of preoperative biliary decompression in Klatskin tumor 52 Radical surgery for
tumor implies extended liver resection. Future liver remnant (preferably at least 30%) must be functionally adequate that is facilitated by preoperative decompression of the bile ducts.
Percutaneous transhepatic selective drainage of segmental bile duct of future liver remnant is of particular importance. This procedure together with increased portal blood flow facilitate fast regeneration and enlargement of liver remnant.
Имя файла: _____МЖ__-новый_17-apr_connent.pptx
Количество просмотров: 48
Количество скачиваний: 0